ArticleBMC public health2025
Global and regional disease burden of HIV/AIDS from 1990 to 2021 and projections to 2030.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Obstetric Mistreatment Among Women Living With HIV.Nursing & health sciences · 2026Pooled it
- The efficacy and mechanism of an integrated mindfulness-based programme on posttraumatic stress disorder among people with HIV: a randomized controlled trial with 3-month follow up.European journal of psychotraumatology · 2026Trial
- Enhancing HIV/AIDS knowledge and attitudes through a healthcare-school collaborative model: a study among Shanghai high school students.AIDS research and therapy · 2025Trial
- HIV Seroprevalence and Screening Practices Among Cancer Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Study From Türkiye.Journal of clinical practice and research · 2026Article
- Viral load suppression and associated factors following enhanced adherence counseling among people living with HIV/AIDS.BMC infectious diseases · 2026Article
- When Stigma Differs: A Cross-Sectional Study of Divergent Associations of Internalized and Enacted Stigma on Human Immunodeficiency Virus Disclosure in Zambia.Health science reports · 2026Article
- Epidemic trends and characteristics of notifiable infectious diseases in mainland China during the COVID-19: a nationwide surveillance study, 2020-2024.Journal of global health · 2026Article
- Knowledge attitudes and practices towards long-acting antiretroviral therapy in HIV/AIDS patients.Scientific reports · 2026Article
- HIV/AIDS burden, attributable risk factors, and projections among reproductive-age adults in China, 1990-2035: A GBD 2023 analysis.PloS one · 2026Article
- Gut feelings and sweet teeth: nutritional solutions to the gut damage in inflammatory bowel disease and HIV infection.Frontiers in nutrition · 2026Review
- Editorial: Defeating HIV in Africa: an achievable goal.Frontiers in public health · 2026Article
- Frequency of Intestinal Parasitic Infection and Associated Factors Among HIV Patients on Antiretroviral Therapy at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia: A 5-Year Retrospective Study.Journal of tropical medicine · 2026Article
- Article
- Avoiding the cost of complacency: barriers and solutions to ending the HIV epidemic in Europe.Frontiers in public health · 2026Article
- Long-term evolution of the burden of HIV/AIDS in older adults: a global burden of disease analysis in individuals aged ≥75 years in G7 countries.Frontiers in public health · 2026Article
- Assessing the knowledge-attitude-practice gap in prevention of mother-to-child transmission of HIV among pregnant and lactating women: a cross-sectional study in Musoma Municipality, Tanzania.BMC public health · 2025Article
- The impact of the recent HIV non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors-based regimens on metabolic health outcomes: A narrative review.Biochemistry and biophysics reports · 2025Review
- Trends in HIV testing and Seroprevalence among key populations at public health centers in South Korea, 2011-2023: a nationwide analysis.BMC public health · 2025Article
- The global disease burden attributable to unsafe sex among women from 1990 to 2021 with forecasts to 2035: a systematic analysis based on the global burden of disease 2021.BMC public health · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundFew studies have focused on the descriptive epidemiology and trends of HIV/AIDS since the publication of the Global Burden of Disease (GBD) study in 2021. Therefore, this study aims to analyze the trends and patterns of the HIV/AIDS burden at the global, regional, and national levels by sex, age and social development index (SDI). We also explored risk factors and predicted the GBD of HIV/AIDS until 2030.
methodsData on the etiology of HIV/AIDS from 1990 to 2021 were collected from the 2021 GBD database. Estimated annual percent changes (EAPCs) were calculated to assess temporal trends in the age-standardized incidence rate (ASIR), age-standardized disability-adjusted life-year rate (ASDR) and age-standardized mortality rate (ASMR) of HIV/AIDS patients. Measures categorized by sex, region, age and SDI quintiles. In addition, an age‒period‒cohort model was established to forecast future trends of the HIV/AIDS burden to 2030.
resultsGlobally, the incidence of HIV/AIDS reached 1.65 million (95% uncertainty interval 1.48 to 1.82) in 2021. From 1990 to 2021, the global ASIR of HIV/AIDS showed a downward trend, with an EAPC of 0.14% (0.12-0.16%). The ASIR, ASDR, and ASMR of HIV/AIDS were highest in the low-SDI region and lowest in the high-SDI region. Regionally, southern sub-Saharan Africa had the highest ASIR in 2021, whereas Oceania had the largest increase in the ASIR from 1990 to 2021. Burundi (EAPC 14.04%, 95% CI -13.63 to -14.44%), followed by Burkina Faso, exhibited the most significant decrease in the ASIR. Globally, the highest incidence rate was observed in the 25-29 years old group. Unsafe sex is the primary factor leading to the burden of HIV/AIDS. By 2030, the global ASIR, ASDR and ASMR of HIV/AIDS are expected to gradually decrease.
conclusionHIV/AIDS disease burden varies by region, sex, and age. The global burden of HIV/AIDS is substantial in low-income regions, especially in Sub-Saharan Africa. Our study offers valuable epidemiological evidence for future research on the prevention and treatment of HIV/AIDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.